9. Wallace, Stephen; Balskus, Emily P. Opportunities for Merging Chemical and Biological Synthesis. Curr. Opin. Biotechnol.2014, 30, 1–8. DOI: https://doi.org/10.1016/j.copbio.2014.03.006.
8. Haiser, Henry J.; Seim, Kristen L.; Balskus, Emily P.; Turnbaugh, Peter J. Mechanistic Insight into Digoxin Inactivation by Eggerthella lenta Augments Our Understanding of Its Pharmacokinetics. Gut Microbes2014, 5, 233–238. DOI: https://doi.org/10.4161/gmic.27915.
7. Waldman, Abraham J.; Balskus, Emily P. Lomaiviticin Biosynthesis Employs a New Strategy for Starter Unit Generation. Org. Lett.2014, 16, 640–643. DOI: https://doi.org/10.1021/ol403714g.
5. Haiser, Henry J.; Gootenberg, David B.; Chatman, Kelly; Sirasani, Gopal; Balskus, Emily P.; Turnbaugh, Peter J. Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta. Science2013, 341, 295–298. DOI: https://doi.org/10.1126/science.1235872.
4. Brotherton, Carolyn A.; Balskus, Emily P. A Prodrug Resistance Mechanism Is Involved in Colibactin Biosynthesis and Cytotoxicity. J. Am. Chem. Soc.2013, 135, 3359–3362. DOI: https://doi.org/10.1021/ja312154m.
3. Nakamura, Hitomi; Balskus, Emily P. Using Chemical Knowledge to Uncover New Biological Function: Discovery of the Cylindrocyclophane Biosynthetic Pathway. Synlett2013, 24, 1464–1470. DOI: https://doi.org/10.1055/s-0033-1338879.